Zevra Therapeutics (ZVRA) Tax Rate Growth (3y) (2017 - 2026)

Zevra Therapeutics (ZVRA) Tax Rate Growth (3y) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Zevra Therapeutics 570.04 Mn 369.43 Mn 34.32 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1,466.00
Dec 31, 2025 282.00
Jun 30, 2025 303.00
Mar 31, 2025 -6,162.00
Dec 31, 2024 -7,419.00
Sep 30, 2023 -285.00
Dec 31, 2022 100.00
Jun 30, 2022 -27.00
Mar 31, 2022 -10.00
Dec 31, 2021 -164.00
Sep 30, 2020 108.00
Dec 31, 2019 9.00
Sep 30, 2019 -4.00
Jun 30, 2019 14.00
Mar 31, 2019 48.00
Dec 31, 2018 35.00
Sep 30, 2018 60.00
Mar 31, 2018 15.00
Dec 31, 2017 52.00
Sep 30, 2017 -49.00